Loading
AB
Akseera Biosciences Incorporated Stock: price and insider trades · Canada
Akseera Biosciences Incorporated: what insiders have been doing
Every trade that managers of Akseera Biosciences Incorporated disclose to SEDI is tracked on this page. Between 23 October 2025 and 23 October 2026, 1 insider published 4 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Insider buying of Akseera Biosciences Incorporated has been absent for the past year.
With 4 filings in twelve months, the company is quieter than the median of 13 filings across the 2,640 companies we follow on the same exchange.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Last declaration on 10 March 2026
Declarations4 total
2,160,000 sharesCommon SharesTSXSEDI:4677934
19,200 sharesCommon SharesTSXSEDI:4677933
Common SharesTSXSEDI:4646084
200,000 sharesCommon SharesTSXSEDI:4646085
4 of 4 declarations
About Akseera Biosciences Incorporated
Akseera Biosciences Incorporated is a biotechnology company focused on developing innovative health solutions. It is listed on the Toronto Stock Exchange (XTSE).
